Compare up to 4 stocks side by side, across all 7 of StockIQ's scoring categories.
| Category | SERA Sera Prognostics, Inc. | AAPG Ascentage Pharma Group International - American Depository |
|---|---|---|
| Price | $2.04 -2.4% | $15.90 -2.5% |
| StockIQ Score | 41D Weak Risk: High | 41D Weak Risk: High |
| Technical | 32F | 36F |
| Fundamental | 22F | 35F |
| Growth | 56C | 50C- |
| Fair Value | 38F | 38F |
| News | 62C+ | 50C- |
| Quality | 58C | 50C- |
| Risk | 40D | 40D |
Scores are based on real financial data only and do not constitute investment advice. How the score is calculated
SERA and AAPG share identical investor and valuation scores of 38, both rated "WEAK." AAPG slightly outperforms in technical (36 vs. 32) and fundamental (35 vs. 22) categories, while SERA leads in growth (56 vs. 50). AAPG is stronger overall in stability and core metrics, though SERA shows more growth potential.
